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ABSTRACT 
 
We employed an approach using oligonucleotide scanning arrays and computational analysis to conduct a 
systematic analysis of the interaction between catalytic nucleic acids (DNA enzymes or DNAzymes) and long 
RNA targets. A radio-labelled transcript representing mRNA of Xenopus cyclin B5 was hybridised to an array 
of  oligonucleotides  scanning  the  first  120  nucleotides  of  the  coding  region  to  assess  the  ability  of  the 
immobilised  oligonucleotides  to  form  heteroduplexes  with  the  target.  The  hybridisation  revealed 
oligonucleotides showing varying levels of signal intensities along the length of the array, reflecting on the 
variable  accessibility  of  the  corresponding  complementary  regions  in  the  target  RNA.  Deoxyribozymes 
targeting a number of these regions were selected and tested for their ability to cleave the target RNA. The 
mRNA cleavage observed indicates that indeed target accessibility was an important component in the activity 
of deoxyribozymes and that it was important that at least one of the two binding arms was complementary to 
an accessible  site. Computational analysis suggested that intra-molecular folding  of  deoxyribozymes into 
stable  structures  may  also  negatively  contribute  to  their  activity.  10-23  type  deoxyribozymes  generally 
appeared  more  active  than  8-17  type  and  it  was  possible  to predict  deoxyribozymes  with  high  cleavage 
efficiency using scanning array hybridization and computational analysis as guides. The data presented here 
therefore have implications on designing effective DNA enzymes. 
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INTRODUCTION 
 
In  recent  years,  by  using  in  vitro  selection  methods,  a 
number of short DNA sequences called DNA enzymes (or 
DNAzymes)  have  been  identified  that  are  capable  of 
performing  diverse  enzymatic  functions  previously 
assigned to proteins (Breaker, 1997, 1999; Emilsson and 
Breaker,  2002).  These  functions  include  RNA  cleavage 
(Breaker  and  Joyce,  1994;  Breaker,  1997;  Santoro  and 
Joyce,  1997;  Feldman  and  Sen,  2001),  DNA  cleavage 
(Carmi et al, 1998; Carmi and Breaker, 2001), DNA and 
RNA ligation (Cuenoud and Szostak, 1995; Li et al, 2000; 
Levy and Ellington, 2001; Flynn-Charlebois et al, 2003; 
Ricca et al, 2003), DNA phosphorylation (Li et al, 2000; 
Li and Breaker, 2001; Wang et al, 2002), DNA capping 
(Li et al, 2000) and peroxidase activity (Travascio et al, 
1999).  RNA-cleaving  deoxyribozymes  have  been 
employed in a variety of in vitro applications (Stojanovic 
et al, 2000; Okumoto et al, 2002; Cairns et al, 2003; Mei et 
al, 2003; Sohail et al, 2003) and  have also been shown to 
down-regulate  endogenous  and  viral  genes  (Sriram  and 
Banerjea, 2000; Hjiantoniou et al, 200; Fahmy et al, 2006;  
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Zhang et al, 2006) in cell culture models and thus hold 
considerable  potential  in  function  analysis  and  gene 
therapies. 
 
Typically,  DNAzymes  have  a  catalytic  core  sequence 
flanked  by  substrate-recognition  ‘guide  arms’  that  have 
sequence  complementary  to  the  target  nucleic  acid.  A 
critical  step  in  the  DNAzyme-mediated  enzymatic 
processes  is  interaction  between  a  DNAzyme  and  the 
target  nucleic  acid,  RNA  in  the  case  of  RNA-cleaving 
DNAzymes  (deoxyribozymes).  On  binding, 
deoxyribozymes  cleave  the  target  RNA  at  a  specific 
dinucleotide catalytic sequence (e.g., Breaker and Joyce, 
1994; Santoro and Joyce, 1997; Feldman and Sen, 2001) 
and have been shown to catalyse RNA cleavage under a 
number of reaction conditions. Measuring target cleavage 
provides a convenient way to monitor their activity (hence 
their  productive  target  binding  capacity).  Thus, 
deoxyribozymes are not only attractive anti-mRNA tools 
for gene silencing approaches but also present interesting 
models  for  the  study  of  interaction  between 
oligonucleotides and long RNAs, such as mRNAs. 
 
Antisense  oligonucleotides  have  been  commonly 
employed in gene silencing experiments, recruiting RNase 
H  to  cleave  the  RNA  strand  of  DNA:RNA  hybrids. 
Several  previous  studies  suggest  that  target  site 
accessibility  plays  an  important  role  in  the  activity  of 
antisense  oligonucleotides,  and  for  efficient  mRNA 
targeting  with  antisense  reagents,  it  is  important  that 
highly accessible regions are targeted (Sohail et al, 2001; 
Beale et al, 2003; Bohula et al, 2003; Petch et al, 2003).  
 
In the  case  of  an  oligonucleotide hybridisation  with  the 
fully  complementary  target  results  in  a  continuous 
heteroduplex.  However,  the  two  binding  arms  of  a 
deoxyribozyme  represent  two  short  oligonucleotides 
linked  through  intervening  sequence  of  the  catalytic 
domain. Although the accessibility requirements for DNA 
enzymes might be expected to be similar to those of the 
oligonucleotides,  no  direct  supporting  evidence  has  yet 
been  presented.  In  addition,  studies  investigating 
interactions between DNA enzymes and long RNAs are 
rare  (e.g.,  Kurreck  et  al,  2002;  Schubert  et  al,  2003; 
Schubert et al, 2004), and hence this issue requires further 
attention. 
 
Rational  design  of  deoxyribozyme-based  gene  silencing 
strategies  require  efficient  methods  of  selecting  highly 
active  reagents.  “Target  scanning”  is  a  generally  used 
approach  in  which  several  sequential  catalytic  sites  are 
targeted and deoxyribozymes are tested for their efficacy. 
However, unless every target site in the region of interest 
is  laboriously  tested it is  quite possible  to  miss  out  the 
optimum  target  site.  Another  approach  involves  the 
identification  of  accessible  sites  with  antisense 
oligonucleotides  (e.g.,  Kurreck  et  al,  2002)  or 
oligonucleotide  libraries  (Sohail  et  al,  2001)  in 
combination with RNase H. Nevertheless, such approaches 
are  not  efficient  and  do  not  always  predict  active 
deoxyribozymes. (Cairns et al, 2000; Kurreck et al, 2002) 
For example, RNase H can  act  on short heteroduplexed 
regions  (Wu  et  al,  1999)  and,  therefore,  only  partial 
heteroduplex  formation  between  an  antisense 
oligonucleotide and RNA can lead to cleavage of RNA. 
Such short sequences are unlikely to imitate the full length 
of the deoxyribozyme binding arms. Furthermore, the site 
of  RNase  H cleavage  in the  heteroduplex  is  difficult  to 
predict and hence it may be also difficult to predict precise 
sequence  of  the  accessible  site  (Sohail  and  Southern, 
2000). Therefore, RNase H-based analysis alone appears 
insufficient for designing effective catalytic nucleic acid 
and  may  have  contributed  to  previously  reported  low 
efficiencies  of  deoxyribozymes  designed  in  this  manner 
(e.g., Cairns et al, 2000; Cairns et al, 2003). 
 
Scanning arrays provide sophisticated and powerful tools 
to  efficiently  predict  accessible  sites  in  endogenous 
mRNAs;  antisense  reagents  (oligonucleotides  and  small 
interfering RNAs) designed using these arrays have been 
shown to work in a number of in vitro and ex vivo systems 
in a predictable manner (Sohail et al, 2001; Beale et al, 
2003; Bohula et al, 2003; Petch et al, 2003; Sohail et al, 
2005). Surprisingly, it appeared that salt concentration and 
presence or absence of cellular proteins had little effect on 
accessibility of target sites in the various mRNAs. We thus 
decided  to  use  scanning  arrays  to  conduct  systematic 
analysis of the interaction between catalytic nucleic acids 
and  target  RNA,  and  investigated  the  usefulness  of 
scanning arrays in designing effective deoxyribozymes. 
 
MATERIALS AND METHODS 
 
Fabrication of the oligonucleotide array, hybridisation 
and image analysis 
An  oligonucleotide  array  was  made  on  aminated 
polypropylene (Beckman Instruments, Fullerton, USA) as 
previously described (Sohail et al, 2001). Briefly, standard 
nucleotide  CE  phosphoramidites  were  used  in  the 
synthesis which was carried out on an adapted ABI 394 
DNA/RNA synthesiser (Applied Biosystem). A diamond-
shaped  mask  with  42  mm  diagonal was  used  to  deliver 
reagents  to  the  polypropylene  surface  for  the  in  situ 
synthesis of the oligonucleotides. The mask was pressed 
against the polypropylene to create a cell. DNA synthesis 
reagents  were  introduced  at  the  bottom  of  the  cell  and 
removed  either  from  the  top  or  from  the  bottom.  After 
each nucleotide coupling, the mask was displaced by a 2.0 
mm step: the result was a template comprising overlapping 
footprints of the mask, with each smaller diamond shape 
representing  an  individual  oligonucleotide.  The  longest 
oligonucleotides were 21-mers, made along the centre line 
of the array. The array was deprotected in 30% ammonia 
solution at 55
oC for 16 h in a closed chamber. 
 
Hybridisation was done in 1 M NaCl, 10 mM Tris-HCl pH 
7.4, 1 mM EDTA and 0.01% (w/v) SDS at 22
oC for 1 hr in 
a  rolling  tube  or  after  mounting  on  a  glass  plate  as 
described  previously  (Sohail  et  al,  2001;  Sohail  et  al, 
2005).  Autoradiography  and  image  analysis  was  carried 
out as previously described (Sohail et al, 2001). 
 
Oligonucleotide synthesis and purification 
Oligodeoxyribonucleotides/deoxyribozymes  were  synthesised 
on  an  ABI394  DNA/RNA  synthesiser  using  standard 
nucleotide  CE-phosphoramidites  (Cruachem)  and  were  
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desalted  through  NAP-5  columns  (Amersham)  at  least 
twice.  Oligonucleotide  stocks  were  maintained  at  100 
pmol/µl concentration in water at –20°C. See Table 1 for a 
list of oligonucleotides and deoxyribozymes. 
 
In vitro transcription 
Radiolabelled transcripts for probing the scanning arrays 
were  obtained  by  in  vitro  transcription.  The  template 
cyclin  B5  plasmid  was  linearised  with  an  appropriate 
restriction endonuclease. Transcriptions were carried  out 
at 30°C for 90 min in the presence of 20 µCi [α-
32P]UTP 
(<3000  Ci/mmol;  Amersham), 750  µM  each  ATP,  CTP 
and GTP and 18.75 µM UTP with T7 RNA polymerase 
(Promega).  The  products  were  purified  by  filtration 
through  MicroSpin  G-25  columns  (Pharmacia  Biotech) 
and  analysed  on  a  5%  (w/v)  denaturing  polyacrylamide 
gel. 5′-End-labelled transcripts for the RNase H mapping 
were  prepared  in  the  presence  of  50  µCi  [γ-
32P]GTP 
(>5000  Ci/mmol;  Amersham)  essentially  as  described 
above,  except  that  the  concentration  of  unlabelled  GTP 
was 75 µM and that of UTP was 750 µM. 
 
Deoxyribozyme cleavage assay 
The deoxyribozymes were tested for their ability to cleave 
cyclin  B5  mRNA  under  single  turnover  conditions  in  a 
buffer containing 10 mM MgCl2, 20 mM Tris-HCl, pH 7.5 
(Kurreck  et  al,  2002).  The  5’-end-labelled  B5  mRNA 
transcript was mixed with the various deoxyribozymes at 
approximately 1:50 ratio (Kurreck et al, 2002; Schubert et 
al, 2004) and incubated at 30
oC for 2 hr. These reaction 
conditions  were  found  to  be  sufficient  to  achieve 
maximum  cleavage  of  the  target  (data  not  shown).  The 
reactions  were  stopped  by  the  addition  formamide  gel 
loading buffer and the products were resolved in an 8% 
(w/v) denaturing polyacrylamide gel for 20-25 min. 
 
Theoretical folding 
The “bimolecular fold” function of the RNAstructure 
4.3 package (Mathews et al, 2004), we used to calculate 
the predicted structures of deoxyribozyme hybridised to 
the 120 nt cyclin B5 sequence of the array, at 1M NaCl 
and  37
oC.  Folding  on  single  deoxyribozymes  was 
performed  using  the  standard  functions  of  the  same 
package. 
 
RESULTS 
 
Selection of deoxyribozymes 
In order to investigate the role and the effect of target site 
accessibility  on  the  activity  of  deoxyribozymes, 
accessibility profile  of the target RNA was determined 
using a scanning array hybridisation assay (Southern et 
al,  1994;  Sohail  and  Southern,  2000)  since  previously 
used  approaches  employing  candidate  oligonucleotide 
screening and RNase H-based assays (Cairns et al, 2000; 
Kurreck  et  al,  2002)  appeared  insufficient  for  such 
analysis.  Scanning  arrays  provide  an  exhaustive 
accessibility  profile  of  the  target  sequence  and  are, 
therefore, powerful tools for such a study (Sohail et al, 
1999). Based on the accessibility predictions using these 
arrays,  highly  efficient  antisense  reagents  have  been 
designed  for  in  vitro,  ex  vivo  and  in  vivo  applications 
(Sohail et al, 2001; Beale et al, 2003; Bohula et al, 2003; 
Petch et al, 2003; Sohail et al, 2005). 
 
A  scanning  array  against  cyclin  B5  mRNA  of  Xenopus 
laevis was fabricated by in situ oligonucleotide synthesis 
on  the  surface  of  aminated-polypropylene  (Sohail  et  al, 
2001)  (also  see  Materials  and  Methods).  The  array 
represented complements of the first 120 nt of the coding 
sequence and consisted of oligonucleotides ranging in size 
from  monomers  to  21-mers.  Radio-labelled  B5  mRNA 
transcript was hybridised to the array and image analysis 
revealed  accessibility  profile  of  the  target  mRNA  (see 
Figure 1C). We then identified catalytic sites for ‘10-23’ 
and ‘8-17’ deoxyribozymes within this region and based 
on  the  accessibility  profile  designed  a  number  of 
deoxyribozymes containing both 8-17 and 10-23 catalytic 
motifs targeting both accessible and inaccessible regions 
(see Table 1 and Figure 1C).   Hybridisation potency of the  
 
 
 
 
 
Table 1: List of deoxyribozymes 
Name  Sequence 5’￿ ￿ ￿ ￿ 3’ 
DR1  AGCCATATCCGAGCCGGACGACCCAAGA 
DR5  CCAAGTAGGGCTAGCTACAACGACATACTC 
DR29  ATCTGTCTCCGAGCCGGACGAGTACGCA 
DR34  TGTCCATTCCGAGCCGGACGAGTCCTGT 
DR36  ATTGTCCAGGCTAGCTACAACGACTGTCCT 
DR36-43  CGACTGCAGGCTAGCTACAACGAGTCCAGGCTAGCTACAACGACTGTCCT 
DR59  GCCACCATCCGAGCCGGACGACCACCCA 
DR80  CCATGTATCCGAGCCGGACGATTCACTT  
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16-mer  antisense  oligonucleotides   in   the   array  to   B5 
mRNA  transcript  was  used  as  guide  to  designing 
deoxyribozymes,  since  16-mers  represented  the  total 
sequence  length  covered  by  the  two  guide  arms  of  the 
deoxyribozymes.  The  hybridisation  potencies  of  16-mer 
oligonucleotides (and hence target site accessibility) varied 
along the length of the array and, in many cases, even few 
base shifts had considerable effect on binding. It was not 
possible  to  use  hybridisation  potencies  of  7-mers  in  the 
design,  since  these  oligonucleotides  showed  very  little 
hybridisation in the array (data not shown). The most likely 
reason  for  this  lack  of  hybridisation  is  that  such  short 
sequences  do  not  form  stable  heteroduplex  under  these 
experimental conditions (see Mir and Southern, 1999). 
 
Deoxyribozymes DR1 and DR5 targeted inaccessible sites, 
while DR29, DR34, DR36,  DR36-43, DR43, DR59 and 
DR80 targeted sites with varying degree of accessibility 
(Figure 1C). DR36-43 had two catalytic domains separated 
by a 6 nt sequence complementary to the target. Both arms 
of  the  deoxyribozymes  DR1  and  DR5  were 
complementary to inaccessible sites in the mRNA. DR29 
and  DR80  were  complementary  to  accessible  16-mer 
sequences and independently both their guide arms were 
also  complementary  to  individual  accessible  16-mer 
sequences.  DR34,  DR36,  DR43  and  DR59  targeted 
accessible 16-mer sequence; however, individually at least 
one of their arms was complementary to an inaccessible 
16-mer sequence. 
 
We wanted to explore the role of target site accessibility in 
predicting the activity of a particular deoxyribozymes. It 
was of interest to note whether the accessibility to either 
the 5’ or 3’ guide arms of the deoxyribozyme might impart 
greater  activity,  i.e., the  two  guide  arms  behave as  two 
independent  oligonucleotides  (Figure  1A  and  B).  If  the 
deoxyribozyme behaved as a single oligonucleotide, then 
activity would be expected to relate to the accessibility of 
an  oligonucleotide  sequence  complementary  to  both  the 
binding arms. If, however, the binding arms hybridise as 
independent  oligonucleotides  then  the  accessibility  of 
either  arm  would  allow  cleavage  at  the  target  site,  the 
binding  of  an  individual  arm  either  affecting  the  local 
RNA  structure  and  enhancing  accessibility  of  the  RNA 
sequence  complementary  to  the  second  arm,  else 
enhancing the local concentration  of  the complementary 
sequence  and  improving  the  chance  for  productive 
binding.   
 
Cleavage efficiencies of deoxyribozymes – the effect of 
target site accessibility 
The  results  of  cleavage  of  B5  mRNA  by  the  various 
deoxyribozyme are shown in Figure 2. Deoxyribozymes 
DR1 and DR5 targeted inaccessible sites in the target and, 
as expected, did not show any detectable cleavage of the 
transcript while all others cleaved B5 mRNA to a varying 
degree,  with  DR36  producing  the  highest  cleavage. 
Deoxyribozymes  DR29,  DR34  and  DR36  targeted  the 
same highly accessible region of the transcript but cleaved 
the transcript to different extent: while both binding arms 
of DR29 were located within accessible regions, at least 
one of the two arms of DR34 and DR36 was positioned in 
an  inaccessible  region.  The  relative  accessibility  of  the 
deoxyribozymes  dinucleotide  target  site  as  predicted  by 
the  array  (that  is,  the  hybridisation  intensity)  was  a 
superficially poor predictor of deoxyribozyme activity, as 
the  most  accessible  target  site  (DR29)  was  much  less 
active than the comparable 8-17 deoxyribozyme DR34. 
 
Logically, hybridisation of either or both 7-mer guide arms 
is more likely to correctly orientate the deoxyribozyme for 
target site cleavage than chance hybridisation at the target 
dinucleotide  site.  Moreover,  Ota  et  al  (Ota  et  al,  1998) 
showed that the helical structure of the hybridised guide 
arms  affects  the  activity  of  the  deoxyribozyme.  We 
decided to focus on the accessibility and character of the 
guide  arm  sequences,  to  analyse  the  role  of  these 
parameters in predicting deoxyribozyme activity.  
 
We focussed upon the 8-17 deoyribozymes to study this. 
Nearest-neighbour Tm calculations were performed for the 
sequences  of  each  guide  arm,  and  for  both  guide  arms 
combined (data presented in Figure 3A).  
 
Using  the  “bimolecular  fold”  function  of  the 
RNAstructure  4.3  package  (Mathews  et  al,  2004), 
we calculated the predicted structures of deoxyribozyme 
hybridised to the 120 nt cyclin B5 sequence of the array. 
The 8-17 deoxyribozyme is predicted to adopt a common 
fold when fully hybridised to the target sequence (Figure 
3B)  and  this  was  taken  to  represent  the  “active” 
conformation. RNAstructure can predict multiple folds in 
order of descending thermodynamic stability. We tallied 
the  number  of  “active”  fold  configurations  predicted  by 
within  20%  of  the  most  stably  predicted  conformation 
(usually  ~4kjmol
-1).  This  set  of  folds  was  taken  to 
represent  the  most  common  configurations  of  the 
hybridised  deoxyribozyme  allowing  for  thermal 
fluctuations (data presented in Figure 3B). 
  
The hybridisation intensities of the peaks representing the 
guide  arms  of  the  deoxyribozymes  were  also  analysed, 
either  as  an  average  of  the  5’  and  3’  guide  arm 
accessibility, solely 5’ or 3’ accessibility, or as the most 
accessible  guide  arm.  The  order  of  accessibility,  and 
therefore  activity,  was  compared  to  that  predicted  by 
computational  folding  or  Tm  calculation.  The  order  of 
activity  predicted  by  the  array  was  34>29>80>59.  Tm 
calculations  predicted  59>34>29=80,  whereas  RNA 
folding  suggested  59>34=29>80.  The  actual  activity 
observed was of the order 34>59>29>80, which was not 
predicted by any of the analytical methods.  
 
We  performed  the  same  analysis  for  two  10-23 
deoxyribozymes.  DR43  was  predicted  most  active  by 
computational  methods,  whereas  DR36  was  targeted  a 
more  accessible  sites  on  the  array  array,  and  ultimately 
showed greater cleavage activity in vitro.  
 
Although none of the methods presented proved entirely 
accurate, it was possible to draw some information from 
them.  Both  computational  analyses  identified  a  stable 
interaction of DR59 with the target sequence, due to a high 
GC  content  of  the  site.  Although  this  site  is  quite 
inaccessible as predicted by the array, DR59 binds with 
strong  affinity,   and  so,  will  likely  result  in  productive   
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Figure 1. A and B. Moving window of deoxyribozyme complementarity with 16-mer oligonucleotides in the array, with two 
possible modes of interaction. C. Histograms showing accessibility profile of the cyclin B5 mRNA in the first 120 nucleotides at 16-
mer oligonucleotide lengths. It also shows binding sites of the two guide arms, X and Z, of the various deoxyribozymes in the 
histogram. D. Identity of the various deoxyribozymes in the cyclin B5 sequence.   
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Figure 2. A. Cleavage of B5 RNA by the various deoxyribozymes. Two fragments produced by DR36-43 are marked 
with arrows. DR29N and DR36N has a single mutation in the catalytic domain, making them inactive (scR = scrambled 
right arm; scL = scrambled left arm). B. Quantification of cleavage by deoxyribozymes. Quantification for scrambled 
deoxyribozymes is not shown since they did not produce any cleavage. 
 
 
 
cleavage whenever the site is accessible for binding. Array 
accessibility  correctly  predicted  the  relative  activity  of 
deoxyribozyme targeted to more accessible sites, but with 
lower binding affinity. This suggests that both guide arm 
sequences and target structure play a role in predicting the 
activity of a deoxyribozyme.  
 
Effecter  oligonucleotide  provides  additional  evidence 
for the role of target site accessibility 
We further tested the role of RNA target accessibility by 
the application of an effecter oligonucleotide (Sohail et al, 
2005). Using B5 mRNA as target, we previously  found 
that  the  binding  of  an  oligonucleotide  (effecter  F2) 
produced dramatic changes in the structure of target RNA 
and lead to considerable increase in the accessibility of a 
neighbouring sequence (Sohail et al, 2005). Coincidently, 
the binding site of DR80 fell within the region showing 
increased accessibility. This offered a good model system 
to test whether increasing or decreasing accessibility of the 
same  target  site  would  also  alter  the  activity  of  the 
deoxyribozyme in parallel. We performed a cleavage assay 
in  the  presence  of  the  effecter  oligonucleotide  F2.  As 
controls we also tested two other deoxyribozymes: DR59 
whose binding site overlapped with that of F2 and DR36, 
which  had  binding  site  in  the  region  that  showed  only 
minor increase in accessibility in the presence of F2 (see 
Figure 4). The results show that indeed in the presence of 
F2  DR80  showed  enhanced  efficiency,  the  activity  of 
DR59  was  blocked  and  that  the  activity  of  DR36  only 
increased slightly, in line with the observation on the array 
hybridisation (Sohail  et  al,  2005), and  suggesting  target 
site accessibility to be one of the most important factors in 
determining deoxyribozyme activity. 
 
Such array-based approaches also offer a rational way of 
designing  effecter  oligonucleotides  (Wang  et  al,  2002; 
Schubert  et  al,  2004;  Sohail  et  al,  2005)  to  enhance 
deoxyribozyme activity.  In the previous studies, Depankar  
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0.50 0.65 0.80 0.33
Figure 3. A. Graphical representations of Tm calculations for 
deoxyribozyme binding arms. B. Computer folding of B5 RNA 
in the presence of deoxyribozyme oligonucleotides. The 
numbers show relative stability of the structures. C. 
RNAstructure analysis of DR36-43 fold.  
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Figure 4. Autoradiograph of deoxyribozyme cleavage assay in 
the presence of an effector (F2) oligonucleotide. In the presence 
of F2 DR80 showed enhanced activity. DR59 cleavage was 
blocked and that the activity of DR36 only increased slightly, in 
line with the observation on the array (Sohail et al, 2005). 
 
 
 
Sen’s Laboratory developed effecter oligonucleotides that 
made a three-way  junction with the  deoxyribozyme and 
the  target  and  proposed  their  use  in  therapeutic 
applications(Wang et al, 2002). However, their tests were 
based on the use of short RNA targets which is unrealistic 
for  gene  silencing  applications  and  their  attractive 
approach needs further validation with long RNA targets 
(such as mRNAs). In mRNAs the regions of accessibility 
are  generally  short  and  limited  in  length  and  thus 
designing  such  three-way  effecters  may  be  challenging. 
With  the  array-based  approach  it  is  possible  to  select 
effectors that are most likely to enhance deoxyribozyme 
activity.  Such  effecter  mediated  enhancement  of 
deoxyribozyme  activity  may  be  useful  where  a  specific 
sequence  of  interest  is  to  be  targeted  that  is  otherwise 
poorly accessible. 
Deoxyribozyme guide arms recruit RNase H for target 
cleavage   
DR36 was the  most active deoxyribozyme identified  by 
scanning array, and presents a good candidate for further 
studies  ex  vivo.  The  cellular  environment  is  far  more 
complex than that of the in vitro assay, however, and we 
wanted to explore whether the deoxyribozyme guide arms 
could recruit RNase H to cleave the mRNA target at sites 
within the guide arms. A deoxyribozyme cleavage assay 
was performed with the addition of RNase H (Figure 5). In 
the  presence  of  RNase  H,  cleavage  of  the  RNA  target 
occurred  at  the  dinucleotide  specifically  targeted  by  the 
deoxyribozyme, and also at the adjacent guide arms.  This 
observation  suggests  that  guide  arms  can  recruit 
endonucleases  to  sites  of  just  7  base  complementarity. 
Since it is  unrealistic to expect a 7-mer sequence to be 
unique  within  the  genome  when  designing  a 
deoxyribozyme, steps must be taken to ensure that guide 
arms to not induce endonuclease mediated cleavage, such 
as  2’O-Methyl  ribonucleotide  modification  of  these 
sequences. Additionally these potential “off-target” effects 
of deoxyribozymes, due to binding of either guide arm to a 
RNA  must  be  considered  when  evaluating  cell  culture 
results, preferably through genome-wide array analysis of 
mRNA expression. 
 
Dual-domain  Deoxyribozymes  –  specifying  distance 
between cleavage sites 
We examined the effect of combining DR36 and  DR43 
since  they  were  both  active  single  deoxyribozymes  and 
were spaced by a moderate six nucleotide spacer sequence. 
The resultant deoxyribozyme, DR36-43, contained two 10-
23 catalytic domains and three guide arms. Both domains 
cleaved that target (Figure 2A) but to a lesser extent than 
that by the two enzymes DR36 and DR43 separately. RNA 
folding  analysis  indicated  that  the  longer  dual-domain 
deoxyribozyme  oligonucleotide  might  form  more  stable 
internal structures that inhibit the binding to the target site 
(Figure 3C), and therefore lowering the activity of the two 
individual domains.   
 
Although in this particular case we did not see a positive 
effect of the inclusion of two domains, careful engineering 
of  a  dual  domain  enzyme  might  be  useful  in  certain 
applications  that  demand  length  specific  cleavage,  for 
example  the  generation  of  short  RNAs  from  larger  pre-
cursors. 
 
DISCUSSION 
 
There are several factors  that may  affect the activity  of 
antisense oligonulceotides and deoxyribozymes, and these 
factors  must  be  weighed  in  the  rational  design  of 
deoxyribozymes  against  long  target  RNAs.  Particular 
success has been achieved in modifiying deoxyribozymes 
with either 2’OMe ribonucleotides, or Locked nucleic acid 
(LNA) monomers that enhance the oligonucleotide affinity 
for the target RNA (Schmidt et al., 2004). This approach 
validates the importance of binding affinity (measured as 
Tm) in deoxyribozyme design. Accessibility of a sequence 
is  a  pre-requisite  for  binding,  and  so  accessibility  must 
also  be  taken  into  account  when  optimising 
deoxyribozyme   design,  and  accessibility  profiling   has  
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Figure 5. Autoradiograph showing cleavage activity of DR36 
against full length cyclin B5 mRNA in the presence (RnH) and 
absence (C) of RNase H. Other control lanes represent full-length 
cyclin B5 mRNA incubated for 2 hr at 37
0C in the presence or 
absence of RNase H. RNase H mapping reaction contained ~25 
fmol 
32P-end-labelled transcript, 10 mM MgCl2, 50 mM KCl, 50 
mM Tris-HCl pH 7.4, 1 mM DTT, 0.5 U RNase H, 0.5 U RNase 
inhibitor (Promega) and 100pmol of DNAzyme) in a total 
volume of 10 µl. The reactions were incubated at 30°C for 1hr 
and terminated by addition of 10 µl of formamide gel loading 
dye buffer. A 5 µl aliquot was analysed on a 8% (w/v) denaturing 
polyacrylamide gel. 
 
 
been proven effective in designing antisene reagents in a 
number of other systems (Sohail et al, 2001; Beale et al, 
2003; Bohula et al, 2003; Petch et al, 2003; Schubert et al, 
2004). We set out to compare computational methods and 
in vitro accessibility profiling to determine the usefulness 
of both in designing deoxyribozymes.  
 
Though  theoretical  folding  is  often  believed  not  to  be 
accurate in predicting structure of long RNAs (Sohail et al, 
1999;  Ho  et  al,  1998),  it  is  likely  to  produce  correct 
folding  of  short  sequence.  We  folded  deoxyribozymes 
using  the  RNAstructure  package 
(http://rna.urmc.rochester.edu/rnastructure.html) (Mathews 
et al, 2004) together with a 120 nt sequence corresponding 
to  the  first  120  nt  of  the  cyclin  B5  mRNA.  It  is  not 
possible to study interaction of DNA with RNA or vice 
versa - the program will only model both DNA or both 
RNA sequences as input. Since deoxyribozymes are short, 
we  decided  to  use  their  homologous  RNA  sequence  as 
input instead of DNA in the analysis, since we did not find 
significant  difference  in  the  folding  or  DNA  or  RNA 
sequences corresponding to deoxyribozymes. However, in 
the case of target RNA sequence, we preferred to use RNA 
since  its  DNA  homologue  had  a  very  different  fold. 
Although this is not the ideal situation it is the best that the 
computer analysis offers and further developments in the 
algorithms are likely to improve such studies. The stability 
of  the  structure  was  judged  by  the  number  of  correctly 
folded  structures  present  amongst  those  predicted.  The 
rational for this is that a “molten” RNA will adopt several 
low energy structures as it fluctuates. If the majority  of 
these  structures  contain  a  deoxyribozyme  in  the  active 
form then cleavage is more likely to occur. The order of 
activity  predicted  by  this  method  was  essentially 
equivalent  to  the  Tm  analysis  -  59>34>29>80.  Array 
hybridiasation  predicted  an  order  of  activity  of 
34>29>80>59,  and  the  actual  activity  observed  was 
34>59>29>80.  Clearly  both  methods  are able  to  predict 
the  general  order  of  relative  activity,  although  DR59 
defeats the analysis.  
 
DR59 is targeted to a relatively inaccessible region,  yet 
appears  to  form  a  stable  interaction  with  the  target  site 
which  overcomes  this.  To  show  that  enhancing 
accessibility can enhance activity we employed an effecter 
oligonucleotide to disrupt the structure around the DR80 
binding  site,  to  make  it  more  accessible.  The  resulting 
cleavage is greater by a factor of 2 in the presence of the 
effecter,  confirming  that  target  site  accessibility  is  a 
contributing factor.  
 
Accessibility  profiling  predicted  deoxyribozyme  activity 
based  upon  the  maximally  accessible  guide-arm,  rather 
than  specifically  the  5’  or  the  3’  guide-arm.  Noticeable 
also was the potential for non-specific off-target cleavage 
indicated in Figure 5. Both of these results suggest that 
care must be taken that partially complementary sequences 
are not inadvertently targeted for cleavage. Modifications 
that asymmetrically  enhance the  binding affinity  of  one 
arm  over  the  other,  or  inhibit  endonuclease  mediated 
cleavage, might be employed to limit off-target binding in 
cases where complementarity cannot be avoided. 
 
The results presented here indicate that target site affinity 
is  an  important  contributor  to  deoxyribozyme  activity. 
However,  thermodynamic  calculations  alone  cannot 
predict deoxyribozyme activity in silico and accessibility 
profiling  is  necessary  to  predict  the  most  active 
deoxyribozymes in vitro. The design of optimally active 
deoxyribozymes  must  therefore  focus  upon  the  RNA 
target  structure  to  the  same  degree  as  chemical 
modifications of the deoxyribozyme when designing the 
best candidates for catalytic nucleic acid therapeutics. 
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